Tissue Regenix Group plc (AIM:TRX)

Tissue Regenix Group Statistics

Total Valuation

AIM:TRX has a market cap or net worth of GBP 18.88 million. The enterprise value is 25.13 million.

Market Cap	18.88M
Enterprise Value	25.13M

Important Dates

The next estimated earnings date is Friday, September 5, 2025.

Earnings Date	Sep 5, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM:TRX has 71.23 million shares outstanding. The number of shares has increased by 0.86% in one year.

Current Share Class	71.23M
Shares Outstanding	71.23M
Shares Change (YoY)	+0.86%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.94%
Owned by Institutions (%)	60.09%
Float	45.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.82
PB Ratio	0.81
P/TBV Ratio	1.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.56, with an EV/FCF ratio of -6.38.

EV / Earnings	-44.13
EV / Sales	1.10
EV / EBITDA	22.56
EV / EBIT	90.16
EV / FCF	-6.38

Financial Position

The company has a current ratio of 3.46, with a Debt / Equity ratio of 0.36.

Current Ratio	3.46
Quick Ratio	0.97
Debt / Equity	0.36
Debt / EBITDA	7.50
Debt / FCF	-2.12
Interest Coverage	0.38

Financial Efficiency

Return on equity (ROE) is -2.92% and return on invested capital (ROIC) is 0.56%.

Return on Equity (ROE)	-2.92%
Return on Assets (ROA)	0.49%
Return on Invested Capital (ROIC)	0.56%
Return on Capital Employed (ROCE)	0.89%
Revenue Per Employee	248,713
Profits Per Employee	-6,190
Employee Count	92
Asset Turnover	0.65
Inventory Turnover	1.23

Taxes

In the past 12 months, AIM:TRX has paid 230,845 in taxes.

Income Tax	230,845
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.14% in the last 52 weeks. The beta is 0.92, so AIM:TRX's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	-62.14%
50-Day Moving Average	31.36
200-Day Moving Average	46.65
Relative Strength Index (RSI)	17.01
Average Volume (20 Days)	121,584

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:TRX had revenue of GBP 22.88 million and -569,523 in losses. Loss per share was -0.01.

Revenue	22.88M
Gross Profit	10.88M
Operating Income	278,771
Pretax Income	-450,506
Net Income	-569,523
EBITDA	1.03M
EBIT	278,771
Loss Per Share	-0.01

Balance Sheet

The company has 1.49 million in cash and 8.36 million in debt, giving a net cash position of -6.87 million or -0.10 per share.

Cash & Cash Equivalents	1.49M
Total Debt	8.36M
Net Cash	-6.87M
Net Cash Per Share	-0.10
Equity (Book Value)	23.21M
Book Value Per Share	0.33
Working Capital	12.07M

Cash Flow

In the last 12 months, operating cash flow was -1.31 million and capital expenditures -2.64 million, giving a free cash flow of -3.94 million.

Operating Cash Flow	-1.31M
Capital Expenditures	-2.64M
Free Cash Flow	-3.94M
FCF Per Share	-0.06

Margins

Gross margin is 47.55%, with operating and profit margins of 1.22% and -2.49%.

Gross Margin	47.55%
Operating Margin	1.22%
Pretax Margin	-1.97%
Profit Margin	-2.49%
EBITDA Margin	4.50%
EBIT Margin	1.22%
FCF Margin	n/a

Dividends & Yields

AIM:TRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.86%
Shareholder Yield	n/a
Earnings Yield	-3.02%
FCF Yield	-20.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 28, 2023. It was a reverse split with a ratio of 0.01.

Last Split Date	Apr 28, 2023
Split Type	Reverse
Split Ratio	0.01

Scores

AIM:TRX has an Altman Z-Score of -0.72 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.72
Piotroski F-Score	2